Chemical Industry News, Data & Insights

INEOS Nitriles Launches Bio-Based Acetonitrile, Cutting Carbon Footprint by 90%

Key highlights
  • INVIREO™ Acetonitrile is a bio-based solvent for pharmaceuticals like insulin and vaccines.
  • It offers a 90% reduction in carbon footprint via a certified mass balance route.
  • Acetonitrile is essential in pharmaceutical manufacturing, analytical chemistry, and organic synthesis.
  • INEOS is the largest global producer of Acetonitrile, operating in Europe, USA, and Asia.

Introduction to INVIREO™ Acetonitrile

INEOS Nitriles has launched INVIREO™ Acetonitrile, a bio-based solvent crucial for the development, purification, and production of pharmaceuticals, including insulin and vaccines. This innovation marks a significant advancement in sustainable chemical production.

Environmental Impact

Produced through a controlled and certified (ISCC+) mass balance route, INVIREO™ Acetonitrile offers a 90% reduction in carbon footprint compared to conventional acetonitrile. This reduction supports the pharmaceutical industry's efforts to minimize environmental impact.

Applications and Importance

Acetonitrile is a versatile high-purity solvent and chemical intermediate, indispensable in various processes such as pharmaceutical manufacturing, analytical chemistry, battery technology, and organic synthesis. Its unique properties make it essential for synthesizing many pharmaceutical molecules.

Global Production

INEOS is the world's largest producer of Acetonitrile and the only producer operating across Europe, the USA, and Asia, ensuring a reliable supply of this critical chemical worldwide.